NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that, during the second half of 2020, it invested a total of $120 million in four clinical-stage biotech companies as part of the ...
Pfizer has made the first investments through its $500 million Pfizer Breakthrough Growth Initiative (PBGI). Homology Medicines received the biggest piece of the first tranche of PBGI funding, landing ...
The first four investments of the new program will support clinical-stage biotechnology companies while new investments will include companies focused on oncology, rare disease, and inflammation and ...
Pfizer announced yesterday that it has invested $120m in four biotech companies – the first investments made through its newly-established ‘breakthrough growth’ fund. The ‘Pfizer Breakthrough Growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results